Covid-19 Synthetic Minigene Vaccine

Covid-19 Synthetic Minigene Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.

LV-SMENP-DC is a vaccine candidate being developed by Shenzhen Geno-Immune Medical Institute that comprises dendritic cells that are modified with lentiviral vector-expressing synthetic minigene which are based on domains of selected viral proteins. This vaccine is also administered with antigen-specific cytotoxic T lymphocytes (CTLs).

As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.

Trade Name Covid-19 Synthetic Minigene Vaccine
Generic LV-SMENP Vaccine
LV-SMENP Vaccine Other Names Covid-19 Synthetic Minigene Vaccine, Lentiviral Minigene Vaccine, LV-SMENP
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Covid-19 Synthetic Minigene Vaccine
Covid-19 Synthetic Minigene Vaccine

Innovators Monograph

You find simplified version here Covid-19 Synthetic Minigene Vaccine


*** Taking medicines without doctor's advice can cause long-term problems.
Share